But anyone who suffers adverse effects as a direct result of Covid-19 vaccination can expect compensation.

The variant was first identified in May and has now been seen in all of the country's nine provinces.

CEO Andy Hall describes some of the ‘swings and roundabouts’ as the company weathers the pandemic.

Earlier than expected opening comes amid concerns about SA’s slowing vaccination rate, especially among older age groups.

Ramaphosa hails Biovac deal to produce more than 100m doses of Pfizer-BioNTech vaccine in the Mother City.

Growing calls for a tougher lockdown in the country’s economic hub.

Nedbank Private Wealth's Preston Narainsamy on Life Healthcare's Alzheimer's drug and Q1 GDP figures. Sygnia CEO David Hufton unpacks results as passive investing continues to grow. Omri Thomas, director of Abax Investments, talks mandate drift and equities for income.

Alex Duys of Umthombo Wealth talks Mediclinic results and its Spire Health exit. Junaid Limalia, Arrowhead CFO, unpacks the property counter's results as it skips a dividend payout. Anchor's Mike Gresty takes a look at the Naspers/Prosus share swap.

The company is planning to add three mental-health facilities to the 13 it already operates.

Anchor's Martin Smith unpacks Telkom and Netcare results. Andries van Heerden from Afrimat discusses the building materials company's new manganese mining right. Keith McLachlan of Integral Asset Management on control structures and those high voting shares.

Covid-19 continues to impact group, which is still operating below pre-pandemic levels

Seen as another constraint or risk to growth.

Jacques du Plessis - direkteur, Netcare se hospitaal afdeling

Revenue in the six months to March 31 is expected to be between 5.5% and 6.5% lower, the private hospital group said.

Specialist facility in Tshwane is Africa’s first green-rated hospital.